focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSE.L Regulatory News (LSE)

  • There is currently no data for LSE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement Re EC Review of Refinitiv Transaction

22 Jun 2020 16:54

RNS Number : 7052Q
London Stock Exchange Group PLC
22 June 2020
 

Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

 

 

22 June 2020

 

 

Update on the European Commission Review Related to the Planned All Share Acquisition of Refinitiv

 

On 1 August 2019, London Stock Exchange Group plc (LSEG) announced that it had reached definitive terms to acquire Refinitiv in an all share transaction for a total enterprise value of approximately US$27 billion (as at 1 August 2019) (the Transaction).

 

LSEG today notes the European Commission's announcement confirming the commencement of Phase II proceedings in connection with its review of the Transaction. LSEG continues to engage constructively with the European Commission and notes that the Phase II review will enable the European Commission to consider the Transaction in further detail, as would be expected for a global transaction of this nature.

 

LSEG has received a number of antitrust and foreign investment approvals and continues to make progress in relation to the remaining clearances and approvals upon which the Transaction is also conditional. We remain committed to closing the Transaction in 2020.

 

 

 

- Ends -

 

For further information:

 

Media: Gavin Sullivan/ Lucie Holloway

+44 (0)20 7797 1222

Investor Relations: Paul Froud

+44 (0)20 7797 3322

Lucas van Praag, Philip Gawith, Doug Campbell (Teneo)

+44 (0)20 7420 3183

 

 

Further information

This announcement is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the Transaction or otherwise, nor shall there be any sale, issuance or transfer of securities of LSEG in any jurisdiction in contravention of applicable law.

 

Forward looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the Transaction and other information published in connection with the Transaction contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. The forward-looking statements contained in this announcement include statements relating to the expected effects of the Transaction on LSEG and its group, the expected timing and scope of the Transaction and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved.

 

Although LSEG believes that the expectations reflected in such forward-looking statements are reasonable, LSEG can give no assurance that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include the satisfaction of the conditions to the Transaction as well as factors such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as changes in the political, social and regulatory framework, or in economic or technological trends or conditions. Other unknown or unpredictable factors could cause actual results to differ materially from those in the forward-looking statements. Such forward-looking statements should therefore be construed in the light of such factors.

 

None of LSEG or any of its associates or directors, officers or advisers provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations (including under the Listing Rules, the Disclosure Guidance and Transparency Rules and the Prospectus Regulation Rules of the FCA), LSEG is under no obligation, and LSEG expressly disclaims any intention or obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

 

Transaction conditions

Completion of the Transaction is subject to the satisfaction of a number of conditions. Consequently, there can be no certainty that completion of the Transaction will be forthcoming.

 

Transmission of this announcement

Neither this announcement, nor any copy of it may be taken or transmitted directly or indirectly into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction. Any failure to comply with this restriction may constitute a violation of such laws or regulations. Persons into whose possession this announcement or other information referred to therein comes, should inform themselves about, and observe, any restrictions in such laws or regulations.

 

Compliance with laws

This announcement has been prepared for the purpose of complying with the applicable laws and regulations of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRELLFLBQLEBBF
Date   Source Headline
29th Jul 20197:00 amRNSStatement re Press Comment
17th Jul 20199:00 amRNSDirectorate Change
1st Jul 20194:46 pmRNSTotal Voting Rights
1st May 20191:33 pmRNSResult of AGM
1st May 201910:34 amRNSAGM Statement
1st May 20197:00 amRNSTrading Statement
2nd Apr 201910:03 amRNSCapital Markets Division Leadership
1st Apr 201910:32 amRNSBlock listing Interim Review
1st Apr 201910:27 amRNSTotal Voting Rights
28th Mar 20194:01 pmRNSDirector/PDMR Shareholding
25th Mar 20194:01 pmRNSDirector/PDMR Shareholding
22nd Mar 201910:17 amRNSAnnual Financial Report
20th Mar 20191:41 pmRNSDirector/PDMR Shareholding
13th Mar 20192:35 pmRNSDirector/PDMR Shareholding
8th Mar 201910:52 amRNSDirectorate Change
1st Mar 20197:00 amRNSAnnual Financial Report
30th Jan 20197:00 amRNSAcquisition of stake
22nd Jan 201910:37 amRNSInformation Services Division Management Changes
2nd Jan 201910:25 amRNSTotal Voting Rights
28th Dec 201812:44 pmRNSDirectorate Change
14th Dec 20182:43 pmRNSDirectorate Change
14th Dec 20189:24 amRNSAcquisition
4th Dec 20183:44 pmRNSPublication of Final Terms Replacement
4th Dec 20182:58 pmRNSPublication of Final Terms
22nd Nov 201811:21 amRNSDirector/PDMR Shareholding
21st Nov 201811:28 amRNSDirectorate Change
19th Oct 20187:01 amRNS3rd Quarter Trading Statement
19th Oct 20187:00 amRNSAcquisition
11th Oct 20181:10 pmRNSDirectorate Change
5th Oct 20183:36 pmRNSDirector/PDMR Shareholding
1st Oct 20182:57 pmRNSBlock listing Interim Review
1st Oct 20182:56 pmRNSTotal Voting Rights
26th Sep 201810:03 amRNSHolding(s) in Company
25th Sep 201810:23 amRNSDirectorate Change
24th Sep 20183:23 pmRNSHolding(s) in Company
3rd Sep 201810:03 amRNSTotal Voting Rights
9th Aug 20189:22 amRNSDirector/PDMR Shareholding
8th Aug 20184:09 pmRNSDirector/PDMR Shareholding
2nd Aug 20187:00 amRNSHalf-year Report
2nd Jul 201810:00 amRNSDirector Declaration
18th May 201811:28 amRNSDirector/PDMR Shareholding
1st May 20183:46 pmRNSTotal Voting Rights
26th Apr 20183:43 pmRNSDirector/PDMR Shareholding
24th Apr 20182:58 pmRNSResult of AGM
24th Apr 201810:31 amRNSAGM Statement
24th Apr 20187:00 amRNSTrading Statement
18th Apr 20185:29 pmRNSDirector/PDMR Shareholding
13th Apr 20183:00 pmRNSDirector Declaration
13th Apr 20187:00 amRNSDirectorate Change
11th Apr 20182:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.